✨
AI Summary
- Sylke Poehling explains Roche's approach: starting drug development with disease biology.
- An integrated Center of Excellence reduces technical risk by combining expertise.
- Optimizing modality selection based on deep understanding of disease mechanisms.
Guests on This Episode
SP
Sylke Poehling, Ph.D
2 podcast appearances